SCHEMBL25638992

SCHEMBL25638992

NC(=O)C12CCC(NC(=O)COc3ccccc3)(CC1)CC2

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATF4 P18848 6/20 0.59
▸ KMT2A Q03164 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ ALPL P05186 1/20 0.47
▸ ALPI P09923 1/20 0.47
▸ ALPG P10696 1/20 0.47
▸ HPGD P15428 1/20 0.46
▸ GAA P10253 1/20 0.44
▸ RAB9A P51151 3/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ TP53 P04637 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ MAPK10 P53779 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ HSD11B1 P28845 1/20 0.43
▸ HSD11B2 P80365 1/20 0.43
▸ LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25639002 0.87 ATF4 (0.57) ATF4KMT2AMEN1ALPLALPI
SCHEMBL23149159 0.81 ATF4 (0.71) ATF4KMT2AMEN1ALPLALPI
SCHEMBL20998386 0.75 ATF4 (0.64) ATF4KMT2AMEN1ALPLALPI
SCHEMBL22614436 0.75 ATF4 (0.86) ATF4KMT2AMEN1RAB9AALDH1A1
SCHEMBL22656718 0.75 ATF4 (1.00) ATF4KMT2AMEN1RAB9AALDH1A1
SCHEMBL2125504 0.74 ALDH1A1 (0.64) KMT2AMEN1HPGDRAB9AALDH1A1
SCHEMBL25638991 0.74 HSD11B1 (0.41) ATF4KMT2AMEN1HPGDALDH1A1
SCHEMBL30446215 0.74 ATF4 (0.79) ATF4KMT2AMEN1RAB9AALDH1A1
SCHEMBL23149137 0.73 ATF4 (0.89) ATF4KMT2ARAB9ANPC1
SCHEMBL22622716 0.72 ATF4 (0.49) ATF4KMT2AMEN1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192712-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2023-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192712-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 ATF4 1/4885KMT2A 4320/4885MEN1 4714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback